Lakefront Biotherapeutics (LKFT) Operating Margin Growth (1y) (2015 - 2026)
Lakefront Biotherapeutics (LKFT) Operating Margin Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 1,552.00 |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 1,536.00 |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -170.00 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 1,049.00 |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Lakefront Biotherapeutics | 1.86 Bn | -1.54 Bn | 1.91 Mn | -77,124.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -77,124.00 |
| Dec 31, 2025 | -53,594.00 |
| Sep 30, 2025 | -54,464.00 |
| Jun 30, 2025 | 43,896.00 |
| Mar 31, 2025 | -15,861.00 |
| Dec 31, 2024 | 42,650.00 |
| Sep 30, 2024 | -7,942.00 |
| Jun 30, 2024 | -17,573.00 |
| Mar 31, 2024 | -2,883.00 |
| Dec 31, 2023 | 19,129.00 |
| Sep 30, 2023 | 12,644.00 |
| Jun 30, 2023 | 34,129.00 |
| Mar 31, 2023 | 12,250.00 |
| Dec 31, 2022 | 40.00 |
| Sep 30, 2022 | 273,065.00 |
| Jun 30, 2022 | -33,033.00 |
| Mar 31, 2022 | -14,668.00 |
| Dec 31, 2021 | 3,549.00 |
| Sep 30, 2021 | -282,823.00 |
| Jun 30, 2021 | 5,509.00 |